Medical tubing, such as vascular and urinary catheters, feeding tubes and ventilation devices, are used throughout the hospital setting. Notoriously linked to infection due to the nature of its placement – both inside and outside of the body, these tubes often facilitate the growth of dangerous organisms, including superbugs like CRE and MRSA. These devices are handled frequently by healthcare workers to provide care to their patients. During handling, microbes can be introduced to the tubing, colonize the surface and potentially cause infections inside the body. Microorganisms that reside on the patient’s skin can also colonize these devices and cause infections.
In order to combat the growing threat of antibiotic-resistant infections and avoid steep financial penalties for high-infection rates, healthcare organizations are looking to manufactures to better safeguard their products. In the case of medical tubing, manufactures are leveraging antimicrobial technologies that have proven, high-kill rates for the most dangerous strains of bacteria.
Medical tubing that is treated with Sciessent’s Agion® Antimicrobial technology continually prevents the growth of microbes, including resistant strains. With industry-leading efficacy performance, clinical data and a recommendation from the Society for Healthcare Epidemiology of America for use in central venous catheters, Agion Antimicrobial is the solution of choice for medical-device manufacturers to protect medical tubing – and the patients being treated with them.
For more information about Sciessent and how we can improve your implantable devices, please feel free to contact us.
The Agion® Antimicrobial is presently registered by the United States Environmental Protection Agency as a preservative and bacteriostatic agent for use in treated articles under 40 CFR 152.25a. The information presented herein is not intended to support or endorse public health claims for treated articles. The Agion Antimicrobial is also used in medical devices under the Food and Drug Administration in the US; those medical device claims are based on safety and efficacy testing and are limited to those approved by FDA. In the EU, the Agion Antimicrobial is used in medical devices under the Medical Device Directive: those medical device claims are based on safety and efficacy testing and are limited to those approved by the designated Competent Authorities and/or Notified Bodies.